Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Exosomes and RNA
1.2.3 CTCs and ctDNA
1.3 Market by Application
1.3.1 Global Lung Cancer Liquid Biops Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Physicians'Office Laboratories
1.3.4 Clinical Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Liquid Biops Market Perspective (2018-2033)
2.2 Lung Cancer Liquid Biops Growth Trends by Region
2.2.1 Global Lung Cancer Liquid Biops Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Lung Cancer Liquid Biops Historic Market Size by Region (2018-2023)
2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Region (2024-2033)
2.3 Lung Cancer Liquid Biops Market Dynamics
2.3.1 Lung Cancer Liquid Biops Industry Trends
2.3.2 Lung Cancer Liquid Biops Market Drivers
2.3.3 Lung Cancer Liquid Biops Market Challenges
2.3.4 Lung Cancer Liquid Biops Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biops Players by Revenue
3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2018-2023)
3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2018-2023)
3.2 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
3.4 Global Lung Cancer Liquid Biops Market Concentration Ratio
3.4.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2022
3.5 Lung Cancer Liquid Biops Key Players Head office and Area Served
3.6 Key Players Lung Cancer Liquid Biops Product Solution and Service
3.7 Date of Enter into Lung Cancer Liquid Biops Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Liquid Biops Breakdown Data by Type
4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2018-2023)
4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2024-2033)
5 Lung Cancer Liquid Biops Breakdown Data by Application
5.1 Global Lung Cancer Liquid Biops Historic Market Size by Application (2018-2023)
5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Lung Cancer Liquid Biops Market Size (2018-2033)
6.2 North America Lung Cancer Liquid Biops Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Lung Cancer Liquid Biops Market Size by Country (2018-2023)
6.4 North America Lung Cancer Liquid Biops Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer Liquid Biops Market Size (2018-2033)
7.2 Europe Lung Cancer Liquid Biops Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Lung Cancer Liquid Biops Market Size by Country (2018-2023)
7.4 Europe Lung Cancer Liquid Biops Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Liquid Biops Market Size (2018-2033)
8.2 Asia-Pacific Lung Cancer Liquid Biops Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2018-2023)
8.4 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Cancer Liquid Biops Market Size (2018-2033)
9.2 Latin America Lung Cancer Liquid Biops Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Lung Cancer Liquid Biops Market Size by Country (2018-2023)
9.4 Latin America Lung Cancer Liquid Biops Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Liquid Biops Market Size (2018-2033)
10.2 Middle East & Africa Lung Cancer Liquid Biops Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2018-2023)
10.4 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Detail
11.1.2 Biocept Business Overview
11.1.3 Biocept Lung Cancer Liquid Biops Introduction
11.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.1.5 Biocept Recent Development
11.2 EntroGen
11.2.1 EntroGen Company Detail
11.2.2 EntroGen Business Overview
11.2.3 EntroGen Lung Cancer Liquid Biops Introduction
11.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.2.5 EntroGen Recent Development
11.3 Cynvenio Biosystems
11.3.1 Cynvenio Biosystems Company Detail
11.3.2 Cynvenio Biosystems Business Overview
11.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
11.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.3.5 Cynvenio Biosystems Recent Development
11.4 Exosome Diagnostics
11.4.1 Exosome Diagnostics Company Detail
11.4.2 Exosome Diagnostics Business Overview
11.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
11.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.4.5 Exosome Diagnostics Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Clearbridge BioMedics
11.6.1 Clearbridge BioMedics Company Detail
11.6.2 Clearbridge BioMedics Business Overview
11.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
11.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.6.5 Clearbridge BioMedics Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
11.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Agena Bioscience
11.8.1 Agena Bioscience Company Detail
11.8.2 Agena Bioscience Business Overview
11.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
11.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.8.5 Agena Bioscience Recent Development
11.9 Cancer Genetics
11.9.1 Cancer Genetics Company Detail
11.9.2 Cancer Genetics Business Overview
11.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
11.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.9.5 Cancer Genetics Recent Development
11.10 CellMax Life
11.10.1 CellMax Life Company Detail
11.10.2 CellMax Life Business Overview
11.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
11.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.10.5 CellMax Life Recent Development
11.11 Nateras
11.11.1 Nateras Company Detail
11.11.2 Nateras Business Overview
11.11.3 Nateras Lung Cancer Liquid Biops Introduction
11.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.11.5 Nateras Recent Development
11.12 MedGenome
11.12.1 MedGenome Company Detail
11.12.2 MedGenome Business Overview
11.12.3 MedGenome Lung Cancer Liquid Biops Introduction
11.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.12.5 MedGenome Recent Development
11.13 OncoDNA
11.13.1 OncoDNA Company Detail
11.13.2 OncoDNA Business Overview
11.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
11.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.13.5 OncoDNA Recent Development
11.14 Genomic Health
11.14.1 Genomic Health Company Detail
11.14.2 Genomic Health Business Overview
11.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
11.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.14.5 Genomic Health Recent Development
11.15 Trovagene
11.15.1 Trovagene Company Detail
11.15.2 Trovagene Business Overview
11.15.3 Trovagene Lung Cancer Liquid Biops Introduction
11.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.15.5 Trovagene Recent Development
11.16 Fluxion Biosciences
11.16.1 Fluxion Biosciences Company Detail
11.16.2 Fluxion Biosciences Business Overview
11.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
11.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.16.5 Fluxion Biosciences Recent Development
11.17 Biodesix
11.17.1 Biodesix Company Detail
11.17.2 Biodesix Business Overview
11.17.3 Biodesix Lung Cancer Liquid Biops Introduction
11.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.17.5 Biodesix Recent Development
11.18 Epic Sciences
11.18.1 Epic Sciences Company Detail
11.18.2 Epic Sciences Business Overview
11.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
11.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.18.5 Epic Sciences Recent Development
11.19 Shuwen Biotech
11.19.1 Shuwen Biotech Company Detail
11.19.2 Shuwen Biotech Business Overview
11.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
11.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.19.5 Shuwen Biotech Recent Development
11.20 Personal Genome Diagnostics
11.20.1 Personal Genome Diagnostics Company Detail
11.20.2 Personal Genome Diagnostics Business Overview
11.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
11.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.20.5 Personal Genome Diagnostics Recent Development
11.21 Predicine
11.21.1 Predicine Company Detail
11.21.2 Predicine Business Overview
11.21.3 Predicine Lung Cancer Liquid Biops Introduction
11.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2018-2023)
11.21.5 Predicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Exosomes and RNA
Table 3. Key Players of CTCs and ctDNA
Table 4. Global Lung Cancer Liquid Biops Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Lung Cancer Liquid Biops Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Lung Cancer Liquid Biops Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Lung Cancer Liquid Biops Market Share by Region (2018-2023)
Table 8. Global Lung Cancer Liquid Biops Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Lung Cancer Liquid Biops Market Share by Region (2024-2033)
Table 10. Lung Cancer Liquid Biops Market Trends
Table 11. Lung Cancer Liquid Biops Market Drivers
Table 12. Lung Cancer Liquid Biops Market Challenges
Table 13. Lung Cancer Liquid Biops Market Restraints
Table 14. Global Lung Cancer Liquid Biops Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Lung Cancer Liquid Biops Market Share by Players (2018-2023)
Table 16. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2022)
Table 17. Ranking of Global Top Lung Cancer Liquid Biops Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biops Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lung Cancer Liquid Biops Product Solution and Service
Table 21. Date of Enter into Lung Cancer Liquid Biops Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lung Cancer Liquid Biops Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2018-2023)
Table 25. Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2024-2033)
Table 27. Global Lung Cancer Liquid Biops Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2018-2023)
Table 29. Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2024-2033)
Table 31. North America Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Lung Cancer Liquid Biops Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Lung Cancer Liquid Biops Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Lung Cancer Liquid Biops Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Lung Cancer Liquid Biops Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2024-2033) & (US$ Million)
Table 46. Biocept Company Detail
Table 47. Biocept Business Overview
Table 48. Biocept Lung Cancer Liquid Biops Product
Table 49. Biocept Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 50. Biocept Recent Development
Table 51. EntroGen Company Detail
Table 52. EntroGen Business Overview
Table 53. EntroGen Lung Cancer Liquid Biops Product
Table 54. EntroGen Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 55. EntroGen Recent Development
Table 56. Cynvenio Biosystems Company Detail
Table 57. Cynvenio Biosystems Business Overview
Table 58. Cynvenio Biosystems Lung Cancer Liquid Biops Product
Table 59. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 60. Cynvenio Biosystems Recent Development
Table 61. Exosome Diagnostics Company Detail
Table 62. Exosome Diagnostics Business Overview
Table 63. Exosome Diagnostics Lung Cancer Liquid Biops Product
Table 64. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 65. Exosome Diagnostics Recent Development
Table 66. F. Hoffmann-La Roche Company Detail
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product
Table 69. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Clearbridge BioMedics Company Detail
Table 72. Clearbridge BioMedics Business Overview
Table 73. Clearbridge BioMedics Lung Cancer Liquid Biops Product
Table 74. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 75. Clearbridge BioMedics Recent Development
Table 76. Bio-Rad Laboratories Company Detail
Table 77. Bio-Rad Laboratories Business Overview
Table 78. Bio-Rad Laboratories Lung Cancer Liquid Biops Product
Table 79. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 80. Bio-Rad Laboratories Recent Development
Table 81. Agena Bioscience Company Detail
Table 82. Agena Bioscience Business Overview
Table 83. Agena Bioscience Lung Cancer Liquid Biops Product
Table 84. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 85. Agena Bioscience Recent Development
Table 86. Cancer Genetics Company Detail
Table 87. Cancer Genetics Business Overview
Table 88. Cancer Genetics Lung Cancer Liquid Biops Product
Table 89. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 90. Cancer Genetics Recent Development
Table 91. CellMax Life Company Detail
Table 92. CellMax Life Business Overview
Table 93. CellMax Life Lung Cancer Liquid Biops Product
Table 94. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 95. CellMax Life Recent Development
Table 96. Nateras Company Detail
Table 97. Nateras Business Overview
Table 98. Nateras Lung Cancer Liquid Biops Product
Table 99. Nateras Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 100. Nateras Recent Development
Table 101. MedGenome Company Detail
Table 102. MedGenome Business Overview
Table 103. MedGenome Lung Cancer Liquid Biops Product
Table 104. MedGenome Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 105. MedGenome Recent Development
Table 106. OncoDNA Company Detail
Table 107. OncoDNA Business Overview
Table 108. OncoDNA Lung Cancer Liquid Biops Product
Table 109. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 110. OncoDNA Recent Development
Table 111. Genomic Health Company Detail
Table 112. Genomic Health Business Overview
Table 113. Genomic Health Lung Cancer Liquid Biops Product
Table 114. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 115. Genomic Health Recent Development
Table 116. Trovagene Company Detail
Table 117. Trovagene Business Overview
Table 118. Trovagene Lung Cancer Liquid Biops Product
Table 119. Trovagene Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 120. Trovagene Recent Development
Table 121. Fluxion Biosciences Company Detail
Table 122. Fluxion Biosciences Business Overview
Table 123. Fluxion Biosciences Lung Cancer Liquid Biops Product
Table 124. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 125. Fluxion Biosciences Recent Development
Table 126. Biodesix Company Detail
Table 127. Biodesix Business Overview
Table 128. Biodesix Lung Cancer Liquid Biops Product
Table 129. Biodesix Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 130. Biodesix Recent Development
Table 131. Epic Sciences Company Detail
Table 132. Epic Sciences Business Overview
Table 133. Epic Sciences Lung Cancer Liquid Biops Product
Table 134. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 135. Epic Sciences Recent Development
Table 136. Shuwen Biotech Company Detail
Table 137. Shuwen Biotech Business Overview
Table 138. Shuwen Biotech Lung Cancer Liquid Biops Product
Table 139. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 140. Shuwen Biotech Recent Development
Table 141. Personal Genome Diagnostics Company Detail
Table 142. Personal Genome Diagnostics Business Overview
Table 143. Personal Genome Diagnostics Lung Cancer Liquid Biops Product
Table 144. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 145. Personal Genome Diagnostics Recent Development
Table 146. Predicine Company Detail
Table 147. Predicine Business Overview
Table 148. Predicine Lung Cancer Liquid Biops Product
Table 149. Predicine Revenue in Lung Cancer Liquid Biops Business (2018-2023) & (US$ Million)
Table 150. Predicine Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Liquid Biops Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Lung Cancer Liquid Biops Market Share by Type: 2022 VS 2033
Figure 3. Exosomes and RNA Features
Figure 4. CTCs and ctDNA Features
Figure 5. Global Lung Cancer Liquid Biops Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Lung Cancer Liquid Biops Market Share by Application: 2022 VS 2033
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Physicians'Office Laboratories Case Studies
Figure 9. Clinical Diagnostic Laboratories Case Studies
Figure 10. Lung Cancer Liquid Biops Report Years Considered
Figure 11. Global Lung Cancer Liquid Biops Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Lung Cancer Liquid Biops Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Lung Cancer Liquid Biops Market Share by Region: 2022 VS 2033
Figure 14. Global Lung Cancer Liquid Biops Market Share by Players in 2022
Figure 15. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2022
Figure 17. North America Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Lung Cancer Liquid Biops Market Share by Country (2018-2033)
Figure 19. United States Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Lung Cancer Liquid Biops Market Share by Country (2018-2033)
Figure 23. Germany Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2018-2033)
Figure 31. China Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Lung Cancer Liquid Biops Market Share by Country (2018-2033)
Figure 39. Mexico Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Lung Cancer Liquid Biops Market Share by Country (2018-2033)
Figure 43. Turkey Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Lung Cancer Liquid Biops Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 46. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 47. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 48. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 50. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 52. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 53. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 54. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 55. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 56. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 57. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 58. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 59. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 60. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 61. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 62. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 63. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 64. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 65. Predicine Revenue Growth Rate in Lung Cancer Liquid Biops Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed